Forsell described that particular finale sequence as his "pièce de résistance" in Death Stranding 2, a chance to create an ...

Arpeggio Bioscience Inc., a preclinical-stage pharmaceutical company founded by University of Colorado Boulder doctoral program graduates, has raised a $17 million Series A fundraising round that will ...

How can drug developers design therapies around cellular networks rather than a single target? That is the question Arpeggio Biosciences is seeking to answer — and with a new influx of funds. The ...

The biotech sector has been on a rollercoaster ride through 2022. Following 2021, which was filled with record-setting growth and sizable investments in biotech companies, significant obstacles have ...